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must be measured in units that can be aggregated across individuals. This is not necessary for 
the living standards measure, which is used only to rank individuals from richest to poorest. 
First step in concentration curve analysis is to score the indicators of access based on 
discomfort and annoyance caused by unavailability of medicines. The higher scores of 
indicators determine the power of influence on access to medicines. These results will be 
correlated with the following factors: demographic, age, gender; socioeconomic factors: 
ethnicity (Caucasian and non-Caucasian), housing condition, level of education, income 
(monthly family income per head), classified per quintiles.  
Conclusions. The present study provides insights into the socioeconomic factors associated 
with access to medicines in Republic of Moldova. Knowledge about inequalities in access to 
medication is important for health policies to contribute to reducing inequalities in health care 
services use and will be investigated more deeply.  
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Introduction. Pharmacists contribute to reduce the number of medication errors during 
medication review. Assessing the significance of pharmacist interventions (PIs) is essential to 
demonstrate the added value of pharmacists. Methods and tools for assessing the potential 
significance of PIs are diverse and their properties are questionable.  
Aim of the study. Assessment of significance of pharmacist intervention for health system to 
obtain additional resource in clinical pharmacy practice.   
Materials and methods. A systematic review was performed in the databases PubMed (1982 
– March 2020), MEDLINE/EMBASE (2000 - March 2020), (1999 - February 2013), Cochrane 
library (1999-March 2020) and Scientific Electronic Library Online (SCIELO) (2001- 2019) 
in order to collect studies using tools for assessment of potential significance of an individual 
PI. Have been used two groups of keywords as the main search: drug-related problems and 
pharmacist interventions.  
Results. Adverse drug events are the major problems relating to patient safety and wellbeing. 
They are associated with increased rate in morbidity and mortality, extended hospitalizations, 
and higher costs of care. Reviewing literature have been determine that it is possible to classify 
the approaches of assessing the significance of an individual PI into 3 main types: approach 1 
- the evaluation of actual consequences of drug related problems (e.g., actual severity of harm); 
approach 2 - the evaluation of actual consequences after performing a PI and following-up the 
patient (e.g., actual clinical outcomes); or approach 3 - the estimation of potential significance 
of a PI. Term “actual” is used as meaning the entity that has appeared in the patient, while the 
term “potential” referred to the situation in which the possibility that the entity could appear in 
the patient existed. The conceptual models of Donabedian suggested that the quality of 
healthcare interventions could be assessed through three types of indicators related to 
“structural features”- appropriate resources and system design; “process of care”- the method 
by which health care is provided; and “outcome”- the consequence of the health care provided, 
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this model is called “structure-process-outcome”. The Kozma model, place outcomes into three 
categories - economic, clinical, and humanistic Outcomes (ECHO model) which characterize 
the value of pharmaceutical services. According to risk model, risks are analyzed by combining 
severity of consequences and probability in the context of existing situation, in PI are evaluated 
medication errors. According to the basic model of pharmacoeconomics, the value of a PI 
considers both inputs and outputs of a PI compared to the absence of a PI. Inputs can be thought 
of as resources required implementing the PI. Outputs can be thought of as consequences of a 
PI, in form of clinical, humanistic, or process-related consequences. The difference between 
the cost of the original therapy and the new therapy gives the cost savings (or the increase in 
the cost of therapy). Cost avoidance refers to the prevention of additional health resources 
which are required to treat drug adverse events if a pharmacist has not intervened such as a 
hospitalization or a medical visit. Cost of implementation of a PI refers to the expenses of 
providing the PI such as cost of pharmacist’s time, phone calls.   
Conclusions. Various structures and contents of tools for evaluation of impacts of PIs were 
highlighted. Majority of tools focused primarily on assessing clinical aspect and failed to detect 
other impacts.  
Key words: pharmacist interventions, pharmacoeconomic model.   
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Introduction. Competition reflects a relationship of forces between the economic agents in the 
market of consumer goods and targeted services for the purpose of attracting the consumer, 
resulting in growth, diversifying and improving the quality of the offer and an increase in 
consumers' demand for goods consummation, being better informed about the existing 
consummation alternatives. The pharmaceutical market has some particularities: a) a large 
number of products with very strict demands on their characteristics, a long period of research 
and a large volume of resources needed for their conditioning; b) consumers of the 
pharmaceutical market are the health system and the sick people, usually economically 
disadvantaged. In order for the effects of competition to be predominantly beneficial, it is 
necessary to regulate it, thus ensuring a balance between the interests of businesses, drug users, 
increasing the number of products offered on the market and ensuring the performances that 
characterize them (harmlessness, effectiveness, quality and accessibility).  
Aim of the study. Highlighting the regulations on the pharmaceutical market of the Republic 
of Moldova and their consequences on competition.  
Materials and methods. The study is based on an analysis of the legal norms for regulating 
some activities related to the pharmaceutical activity and substantiating these rules in terms of 
the effects on competition as an element of the market.  
Results. The pharmaceutical legislation of the Republic of Moldova contains several 
regulations that influence the level of competition in the pharmaceutical market.  1. Expansion 
and placement regulations of pharmacies. These regulations contradict the requirements of the 
market economy, examined from the point of view of the drug trade, but they were introduced 
